Whirlpool Blames Iran Conflict for US Industry Decline Shares Tumble 12 Am Battery ABAT Q1 2026 Results Fall Short EPS 026 Revenue NA Core AI CHAI Stock Jumps 935 Approaching 123 20260518 ON ON Falls 331 Watching 10872 Support 20260515 Vickers Top Insider Picks Analyzing Management Sentiment for May 21 2026 Ryanair Posts Record 226 Billion Profit Up 40 Despite Boeing Delays and Fuel Market Turmoil Ensign Group Inc ENSG Slides 37 as Healthcare Sector Faces Pressure Tectonic Therapeutic TECX Q1 2026 Results Fall Short EPS 134 Revenue NA Arabica Coffee Prices Surge to Record High Amid USColombia Trade Tensions Corporate America Defies Slowdown Expectations in Q2 Earnings Season Prediction Market Odds Rise for Fed Rate Hike by July 2027 Illinois Unemployment Rate Holds Steady in September Payroll Employment Shows Minimal Change Morgan Stanley Highlights Potential Turnaround for Franklin Resources BEN Chinas Robot Workforce Strategy Gains Traction Tesla Chief Raises Competitive Concerns JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Uncertainty DRDGOLD Q3 2014 Earnings NarrowerThanExpected Loss Amidst Challenging Gold Market PLMR Q1 2026 Earnings EPS Surpasses Estimates by 301 Amid Modest Stock Pullback White Mountains Insurance Group WTM Q2 2025 Earnings EPS Misses Estimates but Stock Edges Higher EBMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher SpaceX Scrubs Starship Test Flight Eyes Friday Launch for Starship V3 Debut AMWL Q1 2026 Earnings Narrowed Loss Surpasses Expectations Shares Rise XYL Xylem Inc delivers narrow Q1 2026 EPS beat shares dip 213 percent amid muted investor reaction Why Fermi FRMI might be the portfolio Builder you need Pressure Mounts 20260508 GameStops 555 Billion Unsolicited Acquisition Bid for eBay SUZ Suzano posts Q4 profit of 0257 EPS versus 072 loss forecast revenue rises 57 percent shares climb Target Corporation TGT Fundamental Weaknesses Signal Underperformance Risk Amid Broader Retail Sector Headwinds Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval The working capital efficiency at Taylor TMHC Q1 2026 Profit Exceeds Views